A clinical-stage biotechnology company that develops viral immunotherapies targeting solid tumors to stimulate systemic anticancer immune responses.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Istari Oncology is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of solid tumors. Their lead candidate, lerapolturev (formerly PVSRIPO), is a viral immunotherapy derived from the live attenuated Sabin type 1 oral polio vaccine, designed to stimulate a systemic anticancer immune response. Lerapolturev targets the poliovirus receptor CD155, which is present on virtually all solid tumor types, offering potential across a wide range of cancers.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Istari Oncology Management Team
Istari Oncology Valuations & Financials
View real-time NPM data on Istari Oncology stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Istari Oncology
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Curology
Health Care
Offers personalized prescription skin care medications delivered directly to you.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
FAQ
We have answers
Istari Oncology stock does not trade on public stock exchanges. Istari Oncology stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Istari Oncology stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Istari Oncology Stock does not trade on public stock exchanges. In order to sell Istari Oncology shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Istari Oncology does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Istari Oncology share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Istari Oncology stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Istari Oncology stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Istari Oncology stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Istari Oncology is a private company and has not had an IPO. There is currently no Istari Oncology IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Istari Oncology IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
